Simplex Trading’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.7K Sell
9,401
-4,220
-31% -$6.09K ﹤0.01% 7168
2026
Q1
$17.3K Buy
+13,621
New +$25.6K ﹤0.01% 6890
2025
Q3
– Sell
-15,513
Closed -$53.1K – 9429
2025
Q2
$58K Buy
+15,513
New +$61K ﹤0.01% 5772
2025
Q1
– Sell
-14,767
Closed -$104K – 8932
2024
Q4
$104K Sell
14,767
-6,170
-29% -$49.1K ﹤0.01% 5135
2024
Q3
$170K Buy
20,937
+19,847
+1,821% +$143K ﹤0.01% 4685
2024
Q2
$6K Buy
+1,090
New +$7K ﹤0.01% 7767
2024
Q1
– Sell
-3,049
Closed -$27.8K – 9247
2023
Q4
$28K Buy
3,049
+2,302
+308% +$18.8K ﹤0.01% 6623
2023
Q3
$7K Buy
+747
New +$8.92K ﹤0.01% 7418
2023
Q2
– Sell
-582
Closed -$6.93K – 9344
2023
Q1
$6K Sell
582
-2,350
-80% -$30K ﹤0.01% 7909
2022
Q4
$31K Sell
2,932
-18,274
-86% -$176K ﹤0.01% 6419
2022
Q3
$205K Buy
+21,206
New +$281K ﹤0.01% 4577
2022
Q2
– Sell
-3,209
Closed -$54.7K – 10389
2022
Q1
$83K Buy
3,209
+3,201
+40,013% +$90.8K ﹤0.01% 6412
2021
Q4
$0 Buy
+8
New +$365 ﹤0.01% 10840
2021
Q2
– Sell
-703
Closed -$37.5K – 10277
2021
Q1
$32K Sell
703
-210
-23% -$10.2K ﹤0.01% 7063
2020
Q4
$39K Sell
913
-5,766
-86% -$213K ﹤0.01% 6425
2020
Q3
$244K Buy
+6,679
New +$227K ﹤0.01% 3860
2020
Q2
– Sell
-114
Closed -$3.15K – 7884
2020
Q1
$2K Sell
114
-1,134
-91% -$34.6K ﹤0.01% 7188
2019
Q4
$43K Buy
+1,248
New +$41.3K ﹤0.01% 5326

Other funds holding HCAT

Simplex Trading's HCAT Position: Q2 2026 in Review

Simplex Trading reduced its Health Catalyst (HCAT) stake by 31% in Q2 2026, selling an estimated $6.09K and leaving 9,401 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #7168.

Simplex Trading first reported a position in HCAT in Q4 2019 and has held it in 18 quarters since. The position peaked at $244K in Q3 2020. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Simplex Trading held 9,401 shares of Health Catalyst worth $18.7K as of Q2 2026.
  • Simplex Trading sold 4,220 Health Catalyst shares in Q2 2026, an estimated $6.09K.
  • Health Catalyst made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7168 holding.
  • Simplex Trading first reported a position in Health Catalyst in Q4 2019 and has held it in 18 quarters since.
  • Simplex Trading's Health Catalyst position peaked at $244K in Q3 2020.
  • 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.